Inventor · disambiguated record
Andrew A. Welcher
Also filed as: WELCHER ANDREW · WELCHER ANDREW A
22 granted patents·14 pending applications·527 citations·filing 1987–2021
96Inventor score
Files withAMGEN INC25WELCHER ANDREW A4WELCHER ANDREW2AMGEN INC A CORP OF THE STATE1BAYLOR COLLEGE MEDICINE1
Top patents by PatentIndex Score
36 records- 0195US5981245AEPH-like receptor protein tyrosine kinasesAMGEN INC·Filed 1995·Granted Nov 9, 1999·178 cites·10 claims
- 0294US7790859B2Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitorsAMGEN INC·Filed 2007·Granted Sep 7, 2010·24 cites·29 claims
- 0393US7335743B2Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitorsAMGEN INC·Filed 2003·Granted Feb 26, 2008·45 cites·17 claims
- 0493US4888274ARecA nucleoprotein filament and methodsUNIV YALE·Filed 1987·Granted Dec 19, 1989·125 cites·14 claims
- 0586US11230597B2Methods of treatment using an interferon gamma inhibitorAMGEN INC·Filed 2017·Granted Jan 25, 2022·4 cites·29 claims
- 0686US5824303AEck receptor ligandsAMGEN INC·Filed 1995·Granted Oct 20, 1998·61 cites·8 claims
- 0781US8906371B2Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitorsAMGEN INC·Filed 2013·Granted Dec 9, 2014·3 cites·31 claims
- 0881US8529893B2Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitorsWELCHER ANDREW A·Filed 2012·Granted Sep 10, 2013·4 cites·20 claims
- 0976US7041796B2C3b/C4b Complement Receptor-like molecules and uses thereofAMGEN INC·Filed 2002·Granted May 9, 2006·7 cites·12 claims
- 1075US8202976B2Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitorsWELCHER ANDREW A·Filed 2010·Granted Jun 19, 2012·2 cites·28 claims
- 1172US8148109B2Interferon-like proteins and uses thereofWELCHER ANDREW·Filed 2005·Granted Apr 3, 2012·2 cites·13 claims
- 1271US2022144933A1Methods of treatment using an interferon gamma inhibitorAMGEN INC·Filed 2021·Application pending·0 cites
- 1370US5650504ANucleic acids encoding eck receptor ligandsAMGEN INC·Filed 1995·Granted Jul 22, 1997·24 cites·6 claims
- 1468US5981246ANucleic acids encoding EPH-like receptor protein tyrosine kinasesAMGEN INC·Filed 1996·Granted Nov 9, 1999·21 cites·15 claims
- 1567US6656707B2C3b/C4b complement receptor-like molecules and uses thereofAMGEN INC·Filed 2001·Granted Dec 2, 2003·2 cites·19 claims
- 1666US6479250B1Eck receptor ligandsAMGEN INC·Filed 2000·Granted Nov 12, 2002·2 cites·9 claims
- 1761US11156600B2Assay for detecting TH1 and TH2 cell populationsAMGEN INC·Filed 2018·Granted Oct 26, 2021·0 cites·21 claims
- 1859US7811791B2Interferon-like molecules and uses thereofAMGEN INC·Filed 2004·Granted Oct 12, 2010·0 cites·12 claims
- 1959US5716934AEck receptor ligandsAMGEN INC·Filed 1995·Granted Feb 10, 1998·13 cites·17 claims
- 2056US2006287502A1C3b/C4b complement receptor-like molecules and uses thereofAMGEN INC·Filed 2006·Application pending·0 cites
- 2151US2006216287A1EPH-like receptor protein tyrosine kinasesAMGEN INC·Filed 2005·Application pending·0 cites
- 2251US2013142809A1METHODS OF TREATMENT USING AN IFN gamma INHIBITORWELCHER ANDREW A·Filed 2012·Application pending·0 cites
- 2350US2012157666A1Interferon-like proteins and uses thereofWELCHER ANDREW·Filed 2012·Application pending·0 cites
- 2450US2002137137A1Interferon-like molecules and uses thereofAMGEN INC·Filed 2001·Application pending·0 cites
- 2548US2016046709A1Methods of treatment using an interferon gamma inhibitorAMGEN INC·Filed 2015·Application pending·0 cites
- 2646US5599920APeripheral myelin protein coding sequence and methodBAYLOR COLLEGE MEDICINE·Filed 1995·Granted Feb 4, 1997·6 cites·1 claims
- 2746US2003166069A1Interleukin-1 receptor antagonist-like molecules and uses thereofAMGEN INC·Filed 2002·Application pending·0 cites
- 2845US2006024267A1TNFr/OPG-like molecules and uses thereofWELCHER ANDREW A·Filed 2005·Application pending·0 cites
- 2944US2003077246A1TNFr/OPG-like molecules and uses thereofFiled 2002·Application pending·0 cites
- 3042US2006168672A1B7-like molecules and uses thereofAMGEN INC·Filed 2005·Application pending·0 cites
- 3142US2004208872A1Nucleic encoding interleukin-1 receptor antagonist-like proteins and uses thereofAMGEN INC A CORP OF THE STATE·Filed 2003·Application pending·0 cites
- 3242US2006030005A1C3b/C4b complement receptor-like molecules and uses thereofAMGEN INC·Filed 2005·Application pending·0 cites
- 3340US10156562B2Assay for detecting Th1 and Th2 cell populationsAMGEN INC·Filed 2015·Granted Dec 18, 2018·0 cites·23 claims
- 3439US2002064823A1CD20/IgE-receptor like molecules and uses thereofFiled 2001·Application pending·0 cites
- 3537US6992175B1Nucleic acids encoding Eph-like receptor tyrosine kinasesAMGEN INC·Filed 1999·Granted Jan 31, 2006·4 cites·8 claims
- 3632US6087167AEck receptor ligandsAMGEN INC·Filed 1997·Granted Jul 11, 2000·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Andrew A. Welcher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →